Matches in SemOpenAlex for { <https://semopenalex.org/work/W1994347761> ?p ?o ?g. }
- W1994347761 endingPage "244" @default.
- W1994347761 startingPage "233" @default.
- W1994347761 abstract "The cytotoxic activity of 10 analogs of the idealized amphipathic helical 21-mer peptide (KAAKKAA)3, where three of the Ala residues at different positions have been replaced with Trp residues, has been investigated. The peptide's cytotoxic activity was found to be markedly dependent upon the position of the Trp residues within the hydrophobic sector of an idealized α-helix. The peptides with Trp residues located opposite the cationic sector displayed no antitumor activity, whereas those peptides with two or three Trp residues located adjacent to the cationic sector exhibited high cytotoxic activity when tested against three different cancer cell lines. Dye release experiments revealed that in contrast to the peptides with Trp residues located opposite the cationic sector, the peptides with Trp residues located adjacent to the cationic sector induced a strong permeabilizing activity from liposomes composed of a mixture of zwitterionic phosphatidylcholine and negatively charged phosphatidylserine (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC)/1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-l-serine (POPS)) (2:1) but not from liposomes composed of zwitterionic phosphatidylcholine, POPC. Fluorescence blue shift and quenching experiments revealed that Trp residues inserted deeper into the hydrophobic environment of POPC/POPS liposomes for peptides with high cytotoxic activity. Through circular dichroism studies, a correlation between the cytotoxic activity and the α-helical propensity was established. Structural studies of one inactive and two active peptides in the presence of micelles using NMR spectroscopy showed that only the active peptides adopted highly coiled to helical structures when bound to a membrane surface. The cytotoxic activity of 10 analogs of the idealized amphipathic helical 21-mer peptide (KAAKKAA)3, where three of the Ala residues at different positions have been replaced with Trp residues, has been investigated. The peptide's cytotoxic activity was found to be markedly dependent upon the position of the Trp residues within the hydrophobic sector of an idealized α-helix. The peptides with Trp residues located opposite the cationic sector displayed no antitumor activity, whereas those peptides with two or three Trp residues located adjacent to the cationic sector exhibited high cytotoxic activity when tested against three different cancer cell lines. Dye release experiments revealed that in contrast to the peptides with Trp residues located opposite the cationic sector, the peptides with Trp residues located adjacent to the cationic sector induced a strong permeabilizing activity from liposomes composed of a mixture of zwitterionic phosphatidylcholine and negatively charged phosphatidylserine (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC)/1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-l-serine (POPS)) (2:1) but not from liposomes composed of zwitterionic phosphatidylcholine, POPC. Fluorescence blue shift and quenching experiments revealed that Trp residues inserted deeper into the hydrophobic environment of POPC/POPS liposomes for peptides with high cytotoxic activity. Through circular dichroism studies, a correlation between the cytotoxic activity and the α-helical propensity was established. Structural studies of one inactive and two active peptides in the presence of micelles using NMR spectroscopy showed that only the active peptides adopted highly coiled to helical structures when bound to a membrane surface." @default.
- W1994347761 created "2016-06-24" @default.
- W1994347761 creator A5003803338 @default.
- W1994347761 creator A5022413477 @default.
- W1994347761 creator A5023650551 @default.
- W1994347761 creator A5025698892 @default.
- W1994347761 creator A5037913175 @default.
- W1994347761 creator A5042190192 @default.
- W1994347761 creator A5047280172 @default.
- W1994347761 creator A5058414241 @default.
- W1994347761 creator A5062093717 @default.
- W1994347761 creator A5088108665 @default.
- W1994347761 creator A5091164296 @default.
- W1994347761 date "2012-01-01" @default.
- W1994347761 modified "2023-10-12" @default.
- W1994347761 title "Relative Spatial Positions of Tryptophan and Cationic Residues in Helical Membrane-active Peptides Determine Their Cytotoxicity" @default.
- W1994347761 cites W1481119266 @default.
- W1994347761 cites W1496368230 @default.
- W1994347761 cites W1504017858 @default.
- W1994347761 cites W1964937304 @default.
- W1994347761 cites W1965243248 @default.
- W1994347761 cites W1970621669 @default.
- W1994347761 cites W1975447383 @default.
- W1994347761 cites W1979636792 @default.
- W1994347761 cites W1981664793 @default.
- W1994347761 cites W1982416589 @default.
- W1994347761 cites W1982746862 @default.
- W1994347761 cites W1983987058 @default.
- W1994347761 cites W1985535231 @default.
- W1994347761 cites W1986191025 @default.
- W1994347761 cites W1986516374 @default.
- W1994347761 cites W1987957868 @default.
- W1994347761 cites W1993323777 @default.
- W1994347761 cites W1995017064 @default.
- W1994347761 cites W1996682404 @default.
- W1994347761 cites W1999232606 @default.
- W1994347761 cites W2002195659 @default.
- W1994347761 cites W2003697928 @default.
- W1994347761 cites W2006767418 @default.
- W1994347761 cites W2009592988 @default.
- W1994347761 cites W2012815507 @default.
- W1994347761 cites W2016945141 @default.
- W1994347761 cites W2026585128 @default.
- W1994347761 cites W2027753449 @default.
- W1994347761 cites W2031213053 @default.
- W1994347761 cites W2032284161 @default.
- W1994347761 cites W2039095462 @default.
- W1994347761 cites W2042790122 @default.
- W1994347761 cites W2045838873 @default.
- W1994347761 cites W2047688464 @default.
- W1994347761 cites W2050147937 @default.
- W1994347761 cites W2057916782 @default.
- W1994347761 cites W2060463651 @default.
- W1994347761 cites W2061764021 @default.
- W1994347761 cites W2069888185 @default.
- W1994347761 cites W2076755375 @default.
- W1994347761 cites W2079468421 @default.
- W1994347761 cites W2086860939 @default.
- W1994347761 cites W2088848851 @default.
- W1994347761 cites W2091622692 @default.
- W1994347761 cites W2092398381 @default.
- W1994347761 cites W2100621506 @default.
- W1994347761 cites W2101322634 @default.
- W1994347761 cites W2114918609 @default.
- W1994347761 cites W2130490129 @default.
- W1994347761 cites W2133365694 @default.
- W1994347761 cites W2140472579 @default.
- W1994347761 cites W2144300444 @default.
- W1994347761 cites W2144868493 @default.
- W1994347761 cites W2145135643 @default.
- W1994347761 cites W2147543171 @default.
- W1994347761 cites W2150729329 @default.
- W1994347761 cites W2151654128 @default.
- W1994347761 cites W2157165549 @default.
- W1994347761 cites W2169821755 @default.
- W1994347761 cites W2170792377 @default.
- W1994347761 cites W2411757394 @default.
- W1994347761 cites W2769966399 @default.
- W1994347761 cites W4292320109 @default.
- W1994347761 doi "https://doi.org/10.1074/jbc.m111.279281" @default.
- W1994347761 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3249074" @default.
- W1994347761 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22057278" @default.
- W1994347761 hasPublicationYear "2012" @default.
- W1994347761 type Work @default.
- W1994347761 sameAs 1994347761 @default.
- W1994347761 citedByCount "44" @default.
- W1994347761 countsByYear W19943477612012 @default.
- W1994347761 countsByYear W19943477612013 @default.
- W1994347761 countsByYear W19943477612014 @default.
- W1994347761 countsByYear W19943477612015 @default.
- W1994347761 countsByYear W19943477612016 @default.
- W1994347761 countsByYear W19943477612017 @default.
- W1994347761 countsByYear W19943477612019 @default.
- W1994347761 countsByYear W19943477612020 @default.
- W1994347761 countsByYear W19943477612021 @default.
- W1994347761 countsByYear W19943477612022 @default.
- W1994347761 countsByYear W19943477612023 @default.
- W1994347761 crossrefType "journal-article" @default.